Health
Children’s Ibuprofen Recall Raises Nationwide Safety Concerns
Health Points
- The recall affects nearly 90,000 bottles of children’s ibuprofen sold nationwide.
- The affected lots are 7261973A and 7261974A, with an expiration date of Jan. 31, 2027.
- Consumers reported a gel-like mass and black particles inside the oral suspension liquid.
Nearly 90,000 bottles of children’s ibuprofen are being pulled from shelves across the country. The U.S. Food and Drug Administration issued the enforcement report after reports of potential contamination in the liquid formula.
Strides Pharma Inc. initiated the voluntary recall after customers discovered unusual substances in the 4-ounce bottles. The affected medicine was manufactured for Taro Pharmaceuticals USA before being distributed to retailers nationwide.
Health officials advise parents to stop using the specific product immediately to avoid any health risks. No further instructions for replacements or refunds have been released at this time.
The FDA describes a Class II situation as one where temporary or medically reversible adverse health consequences may occur and the probability of serious adverse health consequences is remote.
